An overview of chondrosarcoma with a focus on nanoscale therapeutics
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Pharmaceutical Investigation"
DOI: 10.1007/s40005-020-00492-x
Abstract: Chondrosarcoma (CHS) is the second most common sarcoma. However, pathogenesis and etiology of this malignant tumor are still unclear. The primary treatment method for CHS is surgery, and CHS is often resistant to conventional chemotherapy.… read more here.
Keywords: treatment; nanoscale therapeutics; overview chondrosarcoma; focus nanoscale ... See more keywords
Targeted nanoscale therapeutics for myocardial infarction.
Sign Up to like & getrecommendations! Published in 2020 at "Biomaterials science"
DOI: 10.1039/d0bm01677b
Abstract: Nanoscale therapeutics have promise for the administration of therapeutic small molecules and biologics to the heart following myocardial infarction. Directed delivery to the infarcted region of the heart using minimally invasive routes is critical to… read more here.
Keywords: heart; myocardial infarction; nanoscale therapeutics; therapeutics myocardial ... See more keywords